Back
ACADIA Pharmaceuticals Vs. Biogen Industry Stock Comparison
Sell
38
ACAD
ACADIA Pharmaceuticals
Last Price:
14.82
Seasonality Move:
14.68%
Sell
28
BIIB
Biogen
Last Price:
173.77
Seasonality Move:
12.64%
Sell
38
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $14.57. The Score for ACAD is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $174.00. The Score for BIIB is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $14.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 42.57 | Sell |
| Chaikin Money Flow: | -213833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.5 - 15.22) | Sell |
| Bollinger Bands (100): | (14.77 - 17.37) | Sell |
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.88 | Sell |
| Relative Strength Index (14 RSI): | 29.49 | Sell |
| Chaikin Money Flow: | -1645865 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (181.94 - 191.28) | Sell |
| Bollinger Bands (100): | (190.2 - 222.88) | Sell |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.56 | Buy |
| 20-day SMA: | 14.73 | Sell |
| 50-day SMA: | 15.47 | Sell |
| 200-day SMA: | 18.12 | Sell |
| 8-day EMA: | 14.66 | Sell |
| 20-day EMA: | 14.84 | Sell |
| 50-day EMA: | 15.37 | Sell |
| 200-day EMA: | 17.76 | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 182.26 | Sell |
| 20-day SMA: | 185.19 | Sell |
| 50-day SMA: | 193.63 | Sell |
| 200-day SMA: | 214.45 | Sell |
| 8-day EMA: | 181.72 | Sell |
| 20-day EMA: | 185.51 | Sell |
| 50-day EMA: | 192.86 | Sell |
| 200-day EMA: | 214.23 | Sell |
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $0.29 per share.
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $0.47 per share.
ACADIA Pharmaceuticals Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biogen Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||